William Blair Initiates Coverage On Beta Bionics with Market Perform Rating

Benzinga Newsdesk www.benzinga.com Positive 52.6%

Neg 0% Neu 0% Pos 52.6%

William Blair analyst Steven Lichtman initiates coverage on Beta Bionics (NASDAQ:BBNX) with a Market Perform rating.

Comments

No comments yet. Be the first!